Evaluation of Heparin as a potentially interfering substance [Bioanalytics]

posted by Monic  – India, 2019-09-11 14:04  – Posting: # 20584
Views: 947

(edited by Monic on 2019-09-11 14:16)

Hi everyone,

Is it required to evaluate the interaction of "heparin" with your analyte of interest during concomitant medication effect as a part of bio-analytical method validation parameter?
since heparin is infused during blood collection to prevent formation of blood clots in clinical phase.

Note: The anticoagulant used for the blood collection in vacutainer is K2EDTA.

Thanks


Edit: Category changed; see also this post #1[Helmut]

Complete thread:

Activity
 Admin contact
20,260 posts in 4,265 threads, 1,401 registered users;
online 20 (0 registered, 20 guests [including 10 identified bots]).
Forum time (Europe/Vienna): 16:16 CET

Science is simply common sense at its best that is,
rigidly accurate in observation, and
merciless to fallacy in logic.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5